Topic: anacin-–-effektiv-smärtlindring-med-pålitlig-kvali

A total of 243 pediatric patients 6 to 12 years of age received Xyzal 5 mg once daily in two short-term placebo controlled double-blind trials. The short-term safety data from pediatric patients are based upon two clinical trials in which 243 children with allergic rhinitis (162 males and 81 females 6 to 12 years of age) were treated with Xyzal 5 mg once daily for 4 to 6 weeks, one clinical trial in which 114 children (65 males and 49 females 1 to 5 years of age) with allergic rhinitis or chron...